Magnera Corp (NYSE: MAGN) is a Consumer Defensive company in the Household & Personal Products industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
11.50
-0.20-1.71%
TA
Loading chart...
Snapshot
| Index | - | P/E | - | EPS (ttm) | -3.13 | Insider Own | 1.42% | Shs Outstand | 35.60M | Perf Week | -1.71% |
| Market Cap | 409.40M | Forward P/E | 8.58 | EPS next Y | 1.34 | Insider Trans | - | Shs Float | 35.40M | Perf Month | -4.41% |
| Enterprise Value | 2.09B | PEG | - | EPS next Q | 0.39 | Inst Own | - | Short Float | 5.61% | Perf Quarter | -5.66% |
| Income | -112.00M | P/S | 0.12 | EPS this Y | 125.24% | Inst Trans | - | Short Ratio | 4.74 | Perf Half Y | 12.20% |
| Sales | 3.28B | P/B | 0.40 | EPS next Y | 69.62% | ROA | -2.92% | Short Interest | 1.99M | Perf YTD | -24.04% |
| Book/sh | 28.57 | P/C | 1.46 | EPS next 5Y | 69.62% | ROE | -10.77% | 52W High | 15.52 -25.90% | Perf Year | 1.05% |
| Cash/sh | 7.87 | P/FCF | 3.69 | EPS past 3/5Y | - | ROIC | 3.69% | 52W Low | 7.82 47.06% | Perf 3Y | -62.52% |
| Dividend Est. | - | EV/EBITDA | 11.24 | Sales past 3/5Y | 29.04% 28.46% | Gross Margin | 10.96% | Volatility | 2.74% 3.51% | Perf 5Y | -94.20% |
| Dividend TTM | - | EV/Sales | 0.64 | EPS Y/Y TTM | 29.02% | Oper. Margin | 3.68% | ATR (14) | 0.46 | Perf 10Y | -96.22% |
| Dividend Ex-Date | Jun 30, 2022 | Quick Ratio | 1.57 | Sales Y/Y TTM | 50.16% | Profit Margin | -3.41% | RSI (14) | 38.89 | Recom | 3.00 |
| Dividend Gr. 3/5Y | -18.64% 56.32% | Current Ratio | 2.45 | EPS Q/Q | -9.80% | SMA20 | -4.87% | Beta | 1.74 | Target Price | 17.50 |
| Payout | 0.00% | Debt/Eq | 0.96 | Sales Q/Q | 2.15% | SMA50 | -9.35% | Rel Volume | 1.69 | Prev Close | 11.70 |
| Employees | 8,500 | LT Debt/Eq | 0.96 | Earnings | Nov 19 | SMA200 | -7.09% | Avg Volume | 423.67K | Price | 11.50 |
| IPO Date | Mar 17, 1980 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -278.51% -6.28% | Net Debt/EBITDA | 9.04 | Volume | 715,097 | Change | -1.71% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Mar-20-26 | Downgrade | Wells Fargo | Overweight → Equal Weight | |
| Feb-06-26 | Reiterated | Wells Fargo | Overweight | $18 → $19 |
| Jan-07-26 | Reiterated | Vertical Research | $15 → $16 | |
| Jan-06-26 | Reiterated | Wells Fargo | Overweight | $12 → $18 |
| Nov-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight | |
| Nov-20-25 | Reiterated | Vertical Research | $15 | |
| Oct-15-25 | Reiterated | Wells Fargo | Equal Weight | $16 → $12 |
| May-14-25 | Downgrade | Wells Fargo | Overweight → Equal Weight | $22 → $16 |
| Jan-23-25 | Initiated | Wells Fargo | Overweight | $22 |
Latest News· Times ET
Aug-31-26
Aug-31-2608:00AM
Aug-18-26
Aug-18-2603:10PM
Aug-13-26
Aug-11-26
Aug-11-2611:29PM
Aug-08-26
09:04AM
Magnera Q3 Earnings Call Highlightsmarketbeat.com
Aug-06-26
Aug-05-26
Jul-21-26
Jul-18-26
Jul-18-2604:30AM
Jul-16-26
Jul-16-2606:04AM
Jul-15-26
Jul-10-26
Company
Magnera Corporation manufactures and sells non-woven and related products worldwide. It sells its products primarily into consumer-oriented end markets, such as healthcare, and personal care. The company offers personal care and consumer solution products and components of products including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence. The company also offers tea bags, coffee filters, wipes, cable wrap, filtration, baby diapers and adult incontinence. The company is headquartered in Charlotte, North Carolina.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/27/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,284 | 3,204 | 2,187 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 2,924 | 2,917 | 1,950 | — | — | — | — | — | — | |
| Gross Profit | 360 | 287 | 237 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 205 | 173 | 128 | — | — | — | — | — | — | |
| Research and Development | 0 | 20 | 13 | — | — | — | — | — | — | |
| Other Operating Expense | 34 | 0 | 237 | — | — | — | — | — | — | |
| Operating Income | 121 | 94 | -141 | — | — | — | — | — | — | |
| Interest Expense | 146 | 150 | 3 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -72 | -110 | 9 | — | — | — | — | — | — | |
| Net Income Before Taxes | -97 | -166 | -135 | — | — | — | — | — | — | |
| Income Taxes | 15 | -7 | 19 | — | — | — | — | — | — | |
| Consolidated Net Income | -112 | -159 | -154 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | -112 | -159 | -154 | — | — | — | — | — | — | |
| Net Income | -112 | -159 | -154 | — | — | — | — | — | — | |
| EPS (Recurring) | -3.13 | -4.48 | -4.41 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -3.13 | -4.48 | -4.41 | — | — | — | — | — | — | |
| EPS (Diluted) | -3.13 | -4.48 | -4.41 | — | — | — | — | — | — | |
| EBITDA | 186 | 190 | 236 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.13 | 0.17 | 0.29 | — | — | — | — | — | — | |
| Gross Margin | 10.96 | 8.96 | 10.84 | — | — | — | — | — | — | |
| Operating Margin | 3.68 | 2.93 | -6.45 | — | — | — | — | — | — | |
| Net Margin | -3.41 | -4.96 | -7.04 | — | — | — | — | — | — | |
| Shares Outstanding | 36 | 36 | 35 | — | — | — | — | — | — | |
| Market Capitalization | 414 | 543 | 636 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Urey Jill L. | EVP, GC & Corp Sec | Feb 28 '26 | Option Exercise | 12.95 | 1,571 | 20,344 | 5,655 | Mar 03 |
| Urey Jill L. | EVP, GC & Corp Sec | Feb 24 '26 | Option Exercise | 13.03 | 205 | 2,671 | 4,152 | Feb 26 |
| Begle Curt | President & CEO | Nov 04 '25 | Option Exercise | 8.53 | 18,208 | 155,314 | 18,208 | Nov 06 |
| Till James | EVP, CFO & Treasurer | Nov 04 '25 | Option Exercise | 8.53 | 4,749 | 40,509 | 4,749 | Nov 06 |
| Manroa Tarun | EVP, COO | Nov 04 '25 | Option Exercise | 8.53 | 3,562 | 30,384 | 3,595 | Nov 06 |
| Urey Jill L. | EVP, GC & Corp Sec | Nov 04 '25 | Option Exercise | 8.53 | 1,583 | 13,503 | 4,388 | Nov 06 |
| Marnick Samantha J. | Director | Nov 04 '25 | Option Exercise | 8.53 | 9,501 | 81,044 | 13,501 | Nov 06 |
| Fahnemann Thomas | Director | Nov 04 '25 | Option Exercise | 8.53 | 7,125 | 60,776 | 83,622 | Nov 06 |
| RICKERTSEN CARL J | Director | Nov 04 '25 | Option Exercise | 8.53 | 9,501 | 81,044 | 50,807 | Nov 06 |
| Hall Mary Dean | Director | Nov 04 '25 | Option Exercise | 8.53 | 9,501 | 81,044 | 9,501 | Nov 06 |
| Fogarty Kevin Michael | Director | Nov 04 '25 | Option Exercise | 8.53 | 9,501 | 81,044 | 22,314 | Nov 06 |
| Curless Michael S | Director | Nov 04 '25 | Option Exercise | 8.53 | 9,501 | 81,044 | 9,501 | Nov 06 |
| Salmon Tom | Director | Nov 04 '25 | Option Exercise | 8.53 | 9,501 | 81,044 | 9,501 | Nov 06 |
| Brown Bruce | Director | Nov 04 '25 | Option Exercise | 8.53 | 9,501 | 81,044 | 21,533 | Nov 06 |
| Marnick Samantha J. | Director | Jun 05 '25 | Buy | 12.38 | 4,000 | 49,511 | 4,000 | Jun 05 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.